Back to Screener

Healthcare

Veritas Farms, Inc.(VFRM)

Live Price

Offline

$0.0001

+0.00% today

1Y Change

+0.00%

Window

Jun 20, 2025 โ†’ Jun 12, 2026

Market Cap
โ€”
Revenue Growth
-65.5%
EPS Growth
+23.5%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 20, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Veritas Farms, Inc. (VFRM) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 20, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of -65.5%, EPS growth of +23.5%, a dividend yield of 0.0%. What stands out right now is revenue -65.5%, EPS +23.5%, free cash flow +19.3% with operating margin -514.0% and ROIC -137.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines VFRM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

-65.5% vs +7.6% peer median

Operating Margin

Below sector median

-514.0% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2025 was reported on Oct 27, 2025, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at -65.5% and EPS is at +23.5%, with operating margin around -514.0%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -11.1% over the next 5 trading days and finished higher after 0 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2025
Oct 27, 2025
โ€”+0.0%-33.3%-66.7%
2025
Jun 30, 2025
โ€”+0.0%+0.0%+0.0%
2025
May 29, 2025
โ€”+0.0%+0.0%+0.0%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

VFRM

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

VFRM Max Drawdown

-66.67%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for VFRM and SPY.

Calendar-year return history is still loading or unavailable.
Veritas Farms, Inc. logo

Company Overview

Veritas Farms, Inc.

Other OTC

Veritas Farms, Inc. focuses on producing, marketing, and distributing hemp oils and extracts containing phytocannabinoids. The company's products include capsules, gummies, tinctures, lotions, salves, vape oils, cream, balm sticks, lip balms, and pet chews. It markets and sells its products under the Veritas Farms brand name, as well as through white label and private label custom formulations for distributors and retailers. The company was formerly known as SanSal Wellness Holdings, Inc. and changed its name to Veritas Farms, Inc. in February 2019. Veritas Farms, Inc. is based in Dania Beach, Florida.

Leadership
Thomas E. Vickers
IPO Date
Sep 6, 2017
Employees
17
Street Address
1815 Griffin Road
Mailing
Fort Lauderdale, FL, 33004
Region
Fort Lauderdale, FL, US
Reporting Currency
USD
Investor Line
833 691 4367
Last Updated
May 5, 2026
CIK: 0001669400ISIN: US92347N2071CUSIP: 92347N207
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
โ€”
Price/Sales
0.0
Price/Book
โ€”

Growth

Revenue
-65.5%
EPS
+23.5%
Free Cash Flow
+19.3%

Profitability

Gross Margin
-130.1%
Operating Margin
-514.0%
Net Margin
-483.9%
ROE
-243.8%
ROIC
-137.3%

Balance Sheet

Debt/Equity
โ€”
Current Ratio
1.12

Earnings Reports

๐Ÿ“… Last reportedOct 27, 2025
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
Oct 27, 25
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Jun 30, 25
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
May 29, 25
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Feb 28, 25
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 25, 24
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 26, 24
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
May 28, 24
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 14, 23
-0.03
Est โ€”
โ€”
235.9B
Est โ€”
โ€”
โ€”
Aug 11, 23
-0.03
Est โ€”
โ€”
169.9B
Est โ€”
โ€”
โ€”
May 12, 23
-0.02
Est โ€”
โ€”
209.8B
Est โ€”
โ€”
โ€”
Apr 17, 23
-0.05
Est โ€”
โ€”
115.1B
Est โ€”
โ€”
โ€”
Nov 14, 22
-0.02
Est โ€”
โ€”
100.2B
Est โ€”
โ€”
โ€”
Aug 12, 22
0.01
Est โ€”
โ€”
285.6B
Est โ€”
โ€”
โ€”
May 12, 22
-0.03
Est โ€”
โ€”
482.1B
Est โ€”
โ€”
โ€”
Apr 12, 22
-0.09
Est โ€”
โ€”
1077.7B
Est โ€”
โ€”
โ€”
Nov 13, 21
-0.03
Est โ€”
โ€”
555.9B
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.